WSK IM03
Alternative Names: WSK-IM03Latest Information Update: 28 Apr 2024
At a glance
- Originator Westvac Biopharma
- Class Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for clinical-Phase-Unknown development in Unspecified(Prevention) in China (IM)
- 26 Aug 2021 Westvac Biopharma files an IND application in China for unspecified indication (Prevention) in Q3 of 2022
- 26 Aug 2021 Westvac Biopharma plans dafety evaluation study for Unspecified indication (Prevention) in China (IM) in Q3 of 2021